Jacoline C. Bouvy
Jacoline C. Bouvy publishes mostly in Economics and Econometrics, General Health Professions and Immunology, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Biosimilars and Bioanalytical Methods.
- World rank
- #805,626 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #66,912 of 367,258
- Works
- 45
- Citations
- 1.5k
- Citations per work
- 34.0
What does Jacoline C. Bouvy research?
Jacoline C. Bouvy's work is mostly in Economics, Econometrics and Finance (45%), Pharmacology, Toxicology and Pharmaceutics (10%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences2045.1%
- Everything else1430.4%
- Life Sciences715.5%
- Health Sciences49.0%
- Health Professions35.7%
- Medicine13.3%
- 1Economics and Econometrics45% of their works
- 2General Health Professions6% of their works
- 3Immunology6% of their works
- 4Pharmacology5% of their works
- 5Toxicology5% of their works
- 6Pediatrics, Perinatology and Child Health3% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- Pharmaceutical industry and healthcare
- Pharmacovigilance and Adverse Drug Reactions
- Healthcare cost, quality, practices
- Pharmaceutical studies and practices
- Biomedical Ethics and Regulation
Which keywords describe Jacoline C. Bouvy's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Pharmaceutical Industry, Drug Development Costs, Generic Drugs, Clinical Trials, Adverse Drug Reactions and Biosimilars.
- Regulatory Challenges
- Off-Label Drug Use
- Choosing Wisely
- Research Outcome
- Conflict of Interest
- Biosimilars
- Clinical Trials
- Drug Development Costs
- Quality of Life
- Cost-effectiveness Analysis
- Pharmaceutical Industry
- Generic Drugs
- Adverse Drug Reactions
- Immunogenicity
- Pharmacovigilance
- Signal Detection
- Low-Value Care
- Pediatric Pharmacokinetics
- Stem Cell Regulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Cost-effectiveness Analysis321 topic
- Quality of Life321 topic
- Pharmaceutical Industry242 topics
- Drug Development Costs181 topic
- Generic Drugs181 topic
- Clinical Trials143 topics
- Adverse Drug Reactions102 topics
- Biosimilars71 topic
- Immunogenicity71 topic
- Conflict of Interest61 topic
- Pharmacovigilance61 topic
- Research Outcome61 topic
- Signal Detection61 topic
- Choosing Wisely51 topic
- Low-Value Care51 topic
- Off-Label Drug Use41 topic
- Pediatric Pharmacokinetics41 topic
- Regulatory Challenges41 topic
- Stem Cell Regulation41 topic
Where does Jacoline C. Bouvy work?
Jacoline C. Bouvy's main affiliation in the publication record is National Institute for Health and Care Excellence, United Kingdom.
How many publications and citations does Jacoline C. Bouvy have?
OpenAlex counts 45 works and 1,531 citations for Jacoline C. Bouvy, an h-index of 17, ranking #805,626 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jacoline C. Bouvy. Posts are plain text and can be reported.